Two decades of innovation reveal mixed findings for quality, cost, and utilization—and unclear ways to resolve. The results are in on the impact of value-based payments (VBP) and once again, they're ...

Facing lower reimbursements and growing demands for price transparency, hospitals are demanding more evidence of differentiated value as they select medical device products. Moreover, hospitals are ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. For some time now, changes in the structure and dynamics of ...

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences: WHAT: Webinar Targeted to Life Sciences Executives WHEN: October 11, 2022, 1:00 PM ET TOPIC: The Next-Generation Commercial Model – Questions ...

What’s the best way to improve commercial performance? For biopharma companies, according to a report from Accenture, the answer is investment and innovation. In a five-year study of 15 drugmakers, ...

The pharmaceutical industry is facing unprecedented disruption, necessitating a fundamental shift in how leaders perceive and respond to market dynamics. Traditional commercial models are no longer ...

Biopharmaceutical companies are looking for go-to-market approaches that go beyond customer expectations. Starting with a revolutionized technology platform allows these organizations to create value ...

Open-weight LLMs can unlock significant strategic advantages, delivering customization and independence in an increasingly AI ...

Xero plans to shift third party app developers from a revenue share commercial model to a new tiered-pricing structure based ...